The IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020), the largest annual Congress in the field, will be held in a virtual format for the first time. Opening on August 20th, the WCO-IOF-ESCEO programme will be accessible to the more than 7900 registrants for a further three months after the Congress.
With more than 1600 scientific contributions presented in 210 live and pre-recorded lectures, nine scientific sessions, seven sponsored satellite symposia, and oral and poster presentations from more than 1400 accepted abstracts, the Congress will showcase new clinical research and advances in osteoporosis, osteoarthritis, frailty, sarcopenia, and rare skeletal diseases. The Congress has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 16 European CME credits (ECMEC®s).
ESCEO President and Congress Co-Chair Professor Jean-Yves Reginster stated:
The IOF-ESCEO Congress is a much anticipated annual forum for health professionals in the field. Due to travel restrictions caused by the COVID-19 pandemic, IOF and ESCEO took the difficult decision to transition the live-event to a virtual format. I’m delighted to say that the success of this virtual format has exceeded all our expectations. As reflected in the record number of registrations, the virtual format will allow more delegates to attend than ever before, and lead to extensive uptake of the excellent sessions. Each and every lecture or session, as well as the virtual exhibition booths, can be accessed, at the delegate’s leisure, for a period of three months after the Congress.
The Congress, which attracts rheumatologists, endocrinologists, orthopaedists, geriatricians, gynaecologists and a broad range of other related healthcare professionals, will provide new information about a wide range of topics, including pharmacological and non-pharmacological treatments, risk assessment, nutrition, bone fragility, physical therapy, healthcare policy, secondary fracture prevention, rare bone disease, sarcopenia, and falls prevention, among others.
As well, there will be Award presentations and a dynamic exhibition featuring numerous virtual booths to present new products and services, and dedicated booths to present the work of IOF, ESCEO and member patient and scientific organizations from around the world.
IOF President and Congress Co-Chair Professor Cyrus Cooper added:
Affecting over 1.7 billion people globally, musculoskeletal disorders are the second greatest cause of disability as measured by years lived with disability. There is increasing evidence that the pandemic is having a detrimental impact on musculoskeletal health, due in part to less physical activity and the difficulty in accessing testing and maintaining continuity of treatment. Experts in the field are deeply concerned about the resulting impact on the long-term musculoskeletal health of older adults worldwide. The expected backlog in testing and treatment will certainly pose a challenge to the medical community. This is why, now more than ever, it is vital that IOF and ESCEO, as leading organizations in the field, continue to advance knowledge and education among health professionals through this global Congress.
The Congress abstracts will be published in the scientific journal ‘Osteoporosis International’, Volume 30, Supplement 1, 2020.
World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2020)
Held jointly by IOF and ESCEO, the 2020 virtual edition of this annual Congress is taking place from August 20-22. The WCO-IOF-ESCEO is the world’s largest annual forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. For complete information visit https://virtual.wco-iof-esceo.org #OsteoCongress
The next Congress is planned in London, UK, from April 8-11, 2021
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. www.esceo.org
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 260 patient, medical and research societies, work together to make fracture prevention and healthy mobility a worldwide heath care priority. www.osteoporosis.foundation @iofbonehealth